FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

Incyte's cream for the treatment of moderate atopic dermatitis in adults has been recommended for approval by the European Medicines Agency. The agency issued a positive opinion on Incyte's Opzelura ...

Atopic dermatitis is a chronic skin condition that falls into the category of eczema. Eczema refers to a wide range of inflammatory skin conditions. Atopic dermatitis is the most common form of eczema ...

To prevent further complications, it is important to address skin disorders that occur around stomas. Peristomal skin problems create a unique challenge because certain topical ointments and creams ...

In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. If you’re choosing a present for a special someone ...

Topline results from the Phase 2 TRAPEDS-1 trial showed that tralokinumab demonstrated favorable pharmacokinetic and safety ...

Seborrheic dermatitis, also known as dandruff, is a common flaky, itchy skin condition that affects people of all ages. It’s most often found on your scalp, but it can also develop on other areas of ...

Flaky scalp, itchiness and painful patches can all be signs of scalp dermatitis, an inflammation of the scalp that can have as many causes as it does symptoms. In most cases, it's not a serious ...

Discover safe hair removal tips for eczema-prone skin, including best methods, skin prep, product choices, and aftercare.

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis ...